How much will Herceptin really cost? The money is already there
- PMID: 17158392
- PMCID: PMC1693588
- DOI: 10.1136/bmj.39052.480231.FA
How much will Herceptin really cost? The money is already there
Conflict of interest statement
Competing interests: Over the past 12 months RM has attended advisory boards for Novartis and Pfizer. Over the past 10 years RM has attended educational meetings, received travel grants, honorariums for lectures and advisory boards from a number of pharmaceutical companies, including AstraZeneca, Bayer, Fournier, GlaxoSmithKline, Pfizer, Merck, MSD, and Sanofi-Aventis. RM is a member of the Primary Care Cardiovascular Society and the South Asian Health Foundation. RM is an appraisal committee member in NICE and a participant in NICE guideline development groups.
Comment on
-
How much will Herceptin really cost?BMJ. 2006 Nov 25;333(7578):1118-20. doi: 10.1136/bmj.39008.624051.BE. BMJ. 2006. PMID: 17124225 Free PMC article. Review.
References
-
- Gill K. Statins—the SHA perspective. Achieving clinical efficiency. A practical case study. www.heart.nhs.uk/scripts/default.asp?site_id=23&id=28050 (accessed 24 Nov 2006).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical